EX-32.2 7 tmbr-20211231xex32d2.htm EX-32.2

EXHIBIT 32.2

​

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

​

Joseph Lucchese, Chief Financial Officer of Timber Pharmaceuticals, Inc. (the “Company”), in compliance with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, hereby certify that, to the best of my knowledge, the Company’s Annual Report on Form 10-K for the period ended December 31, 2021 (the “Report”) filed with the Securities and Exchange Commission:

​

●Fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

​

●The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

​

 

/s/ Joseph Lucchese

 

Joseph Lucchese

 

Chief Financial Officer

 

(Principal Financial and Accounting Officer)

 

March 31, 2022

​